[1]
|
Potential Signature Therapeutic Biomarkers TOP2A, MAD2L1, and CDK1 in Colorectal Cancer: A Systems Biomedicine-Based Approach
Biochemical Genetics,
2024
DOI:10.1007/s10528-023-10544-0
|
|
|
[2]
|
Therapeutic and diagnostic applications of exosomes in colorectal cancer
Medical Oncology,
2024
DOI:10.1007/s12032-024-02440-3
|
|
|
[3]
|
Potential Signature Therapeutic Biomarkers TOP2A, MAD2L1, and CDK1 in Colorectal Cancer: A Systems Biomedicine-Based Approach
Biochemical Genetics,
2023
DOI:10.1007/s10528-023-10544-0
|
|
|
[4]
|
Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma
BMC Cancer,
2023
DOI:10.1186/s12885-023-11595-7
|
|
|
[5]
|
Nanotechnology a Boon for Colorectal Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery,
2023
DOI:10.2174/1574892817666221011094619
|
|
|
[6]
|
Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
Biochimie,
2022
DOI:10.1016/j.biochi.2022.01.009
|
|
|
[7]
|
The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
Biomedicines,
2022
DOI:10.3390/biomedicines10071670
|
|
|
[8]
|
The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
Biomedicines,
2022
DOI:10.3390/biomedicines10071670
|
|
|
[9]
|
Dysregulation of vitamin D synthesis pathway genes in colorectal cancer: A case‐control study
Journal of Clinical Laboratory Analysis,
2021
DOI:10.1002/jcla.23617
|
|
|
[10]
|
Colorectal Cancer: From Genetic Landscape to Targeted Therapy
Journal of Oncology,
2021
DOI:10.1155/2021/9918116
|
|
|
[11]
|
Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers
Clinical Medicine Insights: Oncology,
2021
DOI:10.1177/11795549211036419
|
|
|
[12]
|
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
Frontiers in Nanotechnology,
2021
DOI:10.3389/fnano.2021.699266
|
|
|
[13]
|
Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer
Advances in Medical Diagnosis, Treatment, and Care,
2021
DOI:10.4018/978-1-7998-3580-6.ch009
|
|
|
[14]
|
An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines
Cancers,
2020
DOI:10.3390/cancers12102957
|
|
|
[15]
|
Dysregulation of vitamin D synthesis pathway genes in colorectal cancer: A case‐control study
Journal of Clinical Laboratory Analysis,
2020
DOI:10.1002/jcla.23617
|
|
|
[16]
|
An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines
Cancers,
2020
DOI:10.3390/cancers12102957
|
|
|
[17]
|
Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
Medicina,
2019
DOI:10.3390/medicina55010020
|
|
|
[18]
|
Stratification of patients with colorectal cancer without the recorded family history
Oncology Letters,
2019
DOI:10.3892/ol.2019.10018
|
|
|
[19]
|
Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
Medicina,
2019
DOI:10.3390/medicina55010020
|
|
|
[20]
|
Harnessing evolutionary diversification of primary metabolism for plant synthetic biology
Journal of Biological Chemistry,
2019
DOI:10.1074/jbc.REV119.006132
|
|
|
[21]
|
Management of small bowel and pouch neoplasia in hereditary colorectal cancer syndromes
Seminars in Colon and Rectal Surgery,
2018
DOI:10.1053/j.scrs.2018.06.004
|
|
|
[22]
|
Colorectal cancer and medicinal plants: Principle findings from recent studies
Biomedicine & Pharmacotherapy,
2018
DOI:10.1016/j.biopha.2018.08.006
|
|
|
[23]
|
ENHACEMENT OF SOLUBILITY PROFILE OF PLUMBAGIN CONTAINING TABLET AT DIFFERENT COLONIC REGION FOR COLON TARGETING DRUG DELIVERY SYSTEM
INDIAN DRUGS,
2018
DOI:10.53879/id.55.12.11224
|
|
|
[24]
|
Colorectal cancer and medicinal plants: Principle findings from recent studies
Biomedicine & Pharmacotherapy,
2018
DOI:10.1016/j.biopha.2018.08.006
|
|
|
[25]
|
Colorectal cancer and medicinal plants: Principle findings from recent studies
Biomedicine & Pharmacotherapy,
2018
DOI:10.1016/j.biopha.2018.08.006
|
|
|
[26]
|
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway
Oncotarget,
2017
DOI:10.18632/oncotarget.13790
|
|
|
[27]
|
Tumors and Cancers
2017
DOI:10.1201/b22275-25
|
|
|
[28]
|
The Role of Cyclooxygenase-2 in Colorectal Carcinogenesis
Clinical Colorectal Cancer,
2017
DOI:10.1016/j.clcc.2016.09.012
|
|
|
[29]
|
Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review
Expert Review of Gastroenterology & Hepatology,
2017
DOI:10.1080/17474124.2017.1284586
|
|
|
[30]
|
The Transcriptional Activity of LAMP3 Gene Involved in Autophagocytosis in Colorectal Cancer LAMP3 Expression in Colorectal Cancer
Journal of Biosciences and Medicines,
2017
DOI:10.4236/jbm.2017.512004
|
|
|
[31]
|
Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications
Disease Markers,
2016
DOI:10.1155/2016/1987505
|
|
|
[32]
|
Familial colorectal cancer syndromes: an overview of clinical management
Expert Review of Gastroenterology & Hepatology,
2015
DOI:10.1586/17474124.2015.1026328
|
|
|